Methods and Evaluation of Animal Models of Induced Pulmonary Fibrosis

doi:10.3969/j.issn.2095-1396.2019.06.004

Abstract

Abstract:

Pulmonary fibrosis is one of serious pathological changes，caused by chronic lung disease. The etiology is complicated and the prognosis is extremely poor. So far，there is no effective treatment in clinical practice. Especially in the SARS disease that occurred in early 2003，lung damage in many patients is characterized by pulmonary fibrosis. Therefore，it is very meaningful to establish a simple，rapid and effective animal model for its pathogenesis and efficacy research.

Key words: pulmonary fibrosis, animal models, preparation methods, evaluation

CLC Number:

R965

ZHANG Dan-shen1，MA Jia-cheng2. Methods and Evaluation of Animal Models of Induced Pulmonary Fibrosis[J]. Acta Neuropharmacologica, DOI: 10.3969/j.issn.2095-1396.2019.06.004.

References

[1] Robert D Guzy, Ling Li, Craig Smith, et al. Pulmonary fibrosis requires cell-autonomous mesenchymal fibroblast growth factor (FGF) signaling[J]. J Biological Chemistry, 2017, 292 (25):10364.
[2] 张鹤, 高福泉. 特发性肺纤维化发病机制及治疗进展[J].世界最新医学信息文摘, 2019, 19(15): 37-38.
[3] 陈孟毅, 孟爱民. 肺纤维化动物模型及研究进展[J].中国比较医学杂志, 2016, 26(6): 88-93.
[4] J G Clark, K M Kostal, B A Marino. Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production [J]. J Clinical Investigation, 1983, 72 (6): 2082-2091.
[5] 郑向鹏, 滑炎卿, 张国桢, 等. Ⅲ型胶原纤维在实验性特发性肺纤维化早期的动态研究[J].上海医学, 2002, 25(4): 205-209.
[6] 肖洋, 张俊威, 王伟明. 特发性肺间质纤维化动物模型制作探讨[J].吉林医学, 2016, 37(4): 941-943.
[7] 王健. 平阳霉素致犬肺纤维化的影像学基础研究[D].西安: 第四军医大学,1998.
[8] 胡凯, 刘文其, 岳海英, 等. 肿节风对猪放射性肺损伤的防护作用及机制[J].山东医药, 2016, 56(22): 21-23.
[9] 尉传社, 张俊祥, 张阳, 等. 博莱霉素性羊肺纤维化的实验研究(Ⅱ):糖皮质类激素和丹参治疗的CT与病理[J].临床放射学杂志, 2005, 24(2): 166-169.
[10] Schoenberger C I, Stephen I Rennard, Bitterman P B, et al. Paraquat-induced pulmonary fibrosis. Role of the alveolitis in modulating the development of fibrosis[J]. American Review of Respiratory Diseases, 1984, 129(1): 168-173.
[11] Nathachit Limjunyawong, Wayne Mitzner, Maureen R Horton. A mouse model of chronic idiopathic pulmonary fibrosis[J].Physiological Reports, 2014, 2(2)：e00249.
[12] 刘珊, 范桂香, 袁育康, 等. 两种小鼠肺纤维化造模方法的比较[J].西安交通大学学报:医学版, 2004, 25(3): 244-246, 249.
[13] 栾智华, 柴智, 任晋宏, 等. 黄芪糖蛋白对博莱霉素诱导小鼠肺纤维化的干预作用及机制[J].中国老年学杂志, 2019, 39(6): 1411-1413.
[14] Jin Ming, Wang Lin, Wu Yan, et al. Protective effect of hydroxysafflor yellow A on bleomycin-induced pulmonary inflammation and fibrosis in rats[J].Chinese J Integrative Medicine, 2018, 24(1): 32-39.
[15] 杨聪颖, 彭雄群, 阳惠湘, 等. 不同剂量博莱霉素诱导小鼠肺纤维化的差异及动态变化[J].中国实验动物学报, 2013, 21(2):45-51, 94-96.
[16] 李丽娜, 王华, 周蕾, 等. 博莱霉素诱导小鼠肺间质纤维化造模方式的选择[J].中国免疫学杂志, 2010, 26(3): 254-257.
[17] 张成华, 朱庆均, 田景振. 博莱霉素诱导的肺纤维化动物模型评价及应用研究进展[J].中南药学, 2017, 15(4): 472-475.
[18] 袁佺, 庞立健, 郑玮东, 等. IPF动物造模及造模方法研究[J].辽宁中医药大学学报, 2014, 16(7): 89-91.
[19] 李燕飞, 胡长平, 李峰. 肺纤维化动物模型研究进展[J].中南医学科学杂志, 2016, 44(2): 211-215.
[20] Bethany B Moore, William E Lawson, Tim Oury, et al. Animal models of fibrotic lung disease[J].American J Respiratory Cell and Molecular Biologym, 2013, 49(2):167-179.
[21] Jonathan A Kropski, William E Lawson, Lisa R Young, et al. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis[J].Disease Models and Mechanisms, 2013, 6(1):9-17.
[22] Juan M Povedano, Paula Martinez, Juana M Flores, et al. Mice with pulmonary fibrosis driven by telomere dysfunction(article)[J].Cell Reports, 2015, 12(2)：286-299.
[23] 李健, 牛建昭, 王继峰, 等. AdTGF-β1(223/225)气管内注射制备大鼠肺间质纤维化动物模型[J].中国实验动物学报, 2006, 14(1): 5-7.
[24] 齐曼古丽·吾守尔, 夏宇, 巴哈尔古丽·米吉提, 等. 博莱霉素致大鼠肺纤维化模型的建立方法及比较[J].新疆医科大学学报, 2005, 28(6):495-498.
[25] 王鹤, 张广平, 侯红平, 等. 博莱霉素不同给药方式致大鼠肺纤维化模型探讨[J/OL].中国实验方剂学杂志, 2019, 25(11):73-79.1-11.
[26] Decologne N, Wettstein G, Kolb M, et al. Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles(Article)[J].European Respiratory J, 2010, 35(1): 176-185.
[27] 张东伟, 王继峰, 牛建昭, 等. 盐酸博莱霉素致大鼠肺纤维化动物模型HRCT的评价[J].解放军医学杂志, 2004, 29(6): 507-509.
[28] Bethany B Moore, Cory M Hogaboam. Murine models of pulmonary fibrosis[J].Lung Cellular and Molecular Physiology, 2008, 294(2): L152-L160.
[29] 姜晓姝, 王孝铭, 刘晓滨. 雾化吸入平阳霉素法致小白鼠肺纤维化的观察[J].哈尔滨医科大学学报, 1995, 29(1):4-5.
[30] 郭海, 吉福志, 魏凯峰, 等. 养肺活血方对平阳霉素所致肺纤维化大鼠肺部炎症的影响[J].中国实验方剂学杂志, 2012, 18(21): 179-184.
[31] 张纾难, 王辛秋, 李兰群, 等. 益肺化纤方治疗肺纤维化的实验研究[J].中国医药学报, 1999, 14(6): 22-25.
[32] 杨晓燕, 沈杰. 肺纤维化动物模型的研究进展[J].生物技术通讯, 2015, 26(6): 867-870.
[33] 刘京亮. 血液透析联合血液灌流治疗百草枯中毒疗效评估[J].中外医学研究, 2016, 14(1): 45-46.
[34] 王鸾, 赵敏. 急性百草枯中毒机制及治疗进展[J].医学综述, 2017, 23(14): 2790-2793, 2799.
[35] 高燕, 雍政, 黄英, 等. 百草枯建立肺纤维化动物模型的实验研究[J].空军总医院学报, 2003, 19(4): 201-202.
[36] 许露, 张妍蓓, 徐蒙蒙, 等. 肺纤维化小鼠模型建立方法的研究进展[J].国际呼吸杂志, 2018, 38(23): 1830-1834.
[37] 马忠森, 刘文烈, 杨俊玲, 等. 石棉微粒大鼠肺纤维化模型的制作及其意义[J].白求恩医科大学学报,1999, 25(3): 27-28.
[38] Jun Tashiro, Gustavo A Rubio, Andrew H Limper, et al. Exploring animal models that resemble idiopathic pulmonary fibrosis[J].Frontiers in Medicine, 2017, 4:118.
[39] 刘纯杰, 王德文, 高亚兵, 等. 放射性肺纤维化大鼠动物模型的建立及其病变规律[J].中国兽医学报, 2000, 20(6): 576-579.
[40] 夏宇, 齐曼古丽·吾守尔. 肺纤维化动物模型建立及评价的研究进展[J].新疆医科大学学报, 2005, 28(6): 510-512.